Author: Novarum Admin
February 2015, Edinburgh, Scotland – Novarum DX, the world’s leading mobile point of care technology company, specialising in creating smartphone apps for reading and sharing diagnostic test results, has announced it will demo a newly created app which reads a rapid, point of care Ebola test.
Novarum DX is well known within the mHealth marketplace for creating applications to detect results from diagnostic assays, examples being tests for HIV, Legionella, Drugs of Abuse and Bowel Disease, working in close cooperation with some of the world’s leading diagnostics companies. Building on a simple to use diagnostic test from specialist defence diagnostic manufacturer, BBI Detection, Novarum DX has developed an application to read and share the results of BBI’s Ebola test, using nothing but a smartphone. This first of its kind app will be demonstrated at the GSMA Mobile World Congress from the 2nd – 5th March 2015, in Barcelona.
Company Managing Director, Neil Polwart, commented: “With over 23,000 cases globally, over 9,000 Ebola related deaths, and concern over misdiagnosis due to the symptom similarities with malaria, it is clear that something needs to be done to make testing for Ebola simpler and more accessible. One of the issues with point of care testing is the human error risk involved in visually reading a test. Another is the delay in sending tests to a lab for confirmation. Our application addresses both of these issues.
“We are excited to be part of something that really could make a difference to a global crisis. Whether the app is used in West Africa where facilities are limited, for precautionary measures at border control, or indeed to track positive cases of the virus globally, we believe that this simple to use, low cost technology has the potential to impact the spread of Ebola in a very positive way.
Market Development Manager, Nicole Irvine, added: “We are encouraged by the pace at which the global diagnostics industry has responded to the Ebola crisis. 2015 has already seen one of our customers launch a home-use app, created for them by our specialist team, and we expect this year will also see a key Novarum customer achieve FDA clearance of one of our reader solutions. And so, whether in the developed or developing world, we believe Novarum’s technology is about to trigger a revolution in true point of care testing.”
You can visit Novarum DX at Mobile World Congress from the 2nd – 5th March in Hall 7, Booth 7B11. To set up a meeting at the Congress, please email enquiries@null79.170.44.103.